Loading...

CAR-T Advancements Will Expand Global Cancer Therapy Access

Published
25 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-38.0%
7D
-1.1%

Author's Valuation

US$9471.4% undervalued intrinsic discount

AnalystHighTarget Fair Value